Alliances

Strategic and technology alliances enable Genedata to continuously innovate and support emerging experimental technologies. Genedata’s team of dedicated computer and life science experts collaborate with leading organizations to develop and deliver tailored software solutions. Genedata welcomes new opportunities to partner with companies worldwide.

Business Alliances
Developing innovative products through strategic business alliances

Affymetrix technology for analyzing complex genetic information is used by the world's top pharmaceutical, diagnostic, and biotechnology companies, as well as leading academic, government, and nonprofit research institutes.

ChemAxon is a leader in providing Java based chemical software development platforms for the biotechnology and pharmaceutical industries.



GeneGo Inc. develops systems biology technology such as compound-based pathway analysis, and cheminformatics and bioinformatics software for life science research.

 

Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function.

Ingenuity Systems is a leading provider of information solutions and custom services for life science researchers, computational biologists and bioinformaticists, and life science industry suppliers.

Insilico Biotechnology Biotechnology designs and optimizes biotechnological processes for the chemical and pharmaceutical industries and has a unique technology platform for connecting cell model libraries with simulation processes.

PerkinElmer Inc. is a global technology leader driving growth and innovation in health sciences and photonics markets to improve the quality of life.

Thermo Fisher Scientific Inc. is the world leader in serving science with products and services that help accelerate the pace of scientific discovery, and solve a wide range of analytical challenges.

Research Consortia
Contributing to cutting-edge research and development

BaSysBio
BaSysBio, the Bacillus Systems Biology consortium, represents an integrated systems biology project involving 15 research organizations from nine European countries, studying the global regulation of gene transcription in model bacteria.

BioCop
The BioCop project, a consortia of 33 partners representing 16 EU member states, has been constructed to supply regulators, consumers and industry with long-term solutions to the complex problems associated with chemical contaminant monitoring of foodstuffs.

carcinoGENOMICS
The European Commission project carcinoGENOMICS is developing in vitro methods for assessing the carcinogenic potential of compounds.

ERANet PathoGenoMicssncRNAomics
A European research consortium using a systems biology approach to investigate the role of small non-coding RNA (sncRNA) in infectious diseases. ERANet provides novel targets for diagnostics and therapy of the five major high-risk gram-positive human microbial pathogens - Staphylococcus, Streptococcus, Enterococcus, Clostridium, and Listeria.

EuRhythDia is a collaborative project funded by the European Commission within the FP7 programm. The objective of the project is to achieve breakthroughs in the understanding of the causality between inner clock rhythm disturbances and the development of type 2 diabetes/obesity, and to verify whether re-setting the circadian clock through lifestyle interventions (exercise, diet, light exposure and melatonin intake) alters cardiometabolic risk to a clinically relevant degree. The whole consortium consists of 16 partners from different European Countries.

FRISYS
FRISYS, the Freiburg Initiative for Systems Biology, focuses on modeling and systems analysis of signaling processes in growth and differentiation in human cells and a number of model organisms.

HepatoSys
HepatoSys, an interdisciplinary initiative by leading German research centers, aims to understand the physiology and pathophysiology of the human liver cell using a systems biology approach.

INCA
INCA, the Infections and Cancer research initiative, focuses on the role of chronic infection in the development of cancer to find new prevention measures and treatments.

InnoMed PredTox
InnoMed PredTox is a joint Industry and European Commission collaboration to improve drug safety. The consortium is composed of 14 major pharmaceutical companies and several academic and commercial institutions providing computational & laboratory resources.

Kluyver Centre for Genomics and Industrial Fermentation
Kluyver Centre is a joint industry and academic consortium that applies genomics technology to improve industrial fermentation.

MedSys – “Dr. Jekyll & Mr. Hyde”
The German Medical Systems Biology Project (MedSys) is a multidisciplinary project led by leading German research centers to identify novel targets for diagnostics, patient risk assessment, and therapy of infectious disease caused by the opportunistic fungal pathogen Candida albicans.

NewGeneris
NewGeneris is an integrated EU project investigating the role of prenatal and early-life exposure to genotoxic chemicals present in food and the environment.

NTC
The NTC (Netherlands Toxicogenomics Centre) has been initiated by the Netherlands Genomics Initiative. It represents a collaboration of leading knowledge institutes and several companies to identify hazards of chemical compounds and assessing risks of human exposure.

PROLIGEN
The PROLIGEN consortium studies the regenerative capacity of injured kidneys using information derived from genomics, proteomics, and functional genomics.

SysMAP
Founded and coordinated by the leading specialty chemicals producer Evonik Degussa, the SysMAP consortium exploits novel experimental and computational methods to probe the biological mechanisms underlying industrial fermentation